Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients

Clicks: 250
ID: 120325
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
In UC patients, the serum patterns of IL-6 and IL-8 at baseline and over the first 6 weeks of treatment with VDZ could be useful to predict therapeutic outcome.
Reference Key
l2020britishassessment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bertani L;Baglietto L;Antonioli L;Fornai M;Tapete G;Albano E;Ceccarelli L;Mumolo MG;Pellegrini C;Lucenteforte E;de Bortoli N;Bellini M;Marchi S;Blandizzi C;Costa F;;
Journal British journal of clinical pharmacology
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/32027388/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:32027388 pmc7319004 doi:10.1111/bcp.14235 lorenzo bertani laura baglietto francesco costa

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.